Abstract
BackgroundFactors related to the use of biologic disease modifying anti-rheumatic drugs (bDMARDs) in rheumatoid arthritis (RA) have varied in prior studies.ObjectivesThis study aims to identify characteristics at the time of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
